162 related articles for article (PubMed ID: 36810718)
1. Enhanced Expression of Plasminogen Activators and Inhibitor in the Healing of Tympanic Membrane Perforation in Rats.
Makuszewska M; Cieślińska M; Winnicka MM; Skotnicka B; Niemczyk K; Bonda T
J Assoc Res Otolaryngol; 2023 Apr; 24(2):159-170. PubMed ID: 36810718
[TBL] [Abstract][Full Text] [Related]
2. Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis.
Leonardi A; Brun P; Sartori MT; Cortivo R; Dedominicis C; Saggiorato G; Abatangelo G; Secchi AG
Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1364-70. PubMed ID: 15790903
[TBL] [Abstract][Full Text] [Related]
3. Mice deficient in urokinase-type plasminogen activator have delayed healing of tympanic membrane perforations.
Shen Y; Guo Y; Du C; Wilczynska M; Hellström S; Ny T
PLoS One; 2012; 7(12):e51303. PubMed ID: 23236466
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of plasminogen activator and plasminogen activator inhibitor during liver fibrogenesis of rats: role of stellate cells.
Zhang LP; Takahara T; Yata Y; Furui K; Jin B; Kawada N; Watanabe A
J Hepatol; 1999 Oct; 31(4):703-11. PubMed ID: 10551395
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin E2 regulates production of plasminogen activator isoenzymes, urokinase receptor, and plasminogen activator inhibitor-1 in primary cultures of rat calvarial osteoblasts.
Allan EH; Martin TJ
J Cell Physiol; 1995 Dec; 165(3):521-9. PubMed ID: 7593231
[TBL] [Abstract][Full Text] [Related]
6. Localization and distribution of tissue type and urokinase type plasminogen activators and their inhibitors Type 1 and 2 in human and rhesus monkey fetal membranes.
Liu YX; Hu ZY; Liu K; Byrne S; Zou RJ; Ny T; d'Lacey C; Ockleford CD
Placenta; 1998; 19(2-3):171-80. PubMed ID: 9548184
[TBL] [Abstract][Full Text] [Related]
7. Epithelial tissue-type plasminogen activator expression, unlike that of urokinase, its receptor, and plasminogen activator inhibitor-1, is increased in chronic venous ulcers.
Weckroth M; Vaheri A; Virolainen S; Saarialho-Kere U; Jahkola T; Sirén V
Br J Dermatol; 2004 Dec; 151(6):1189-96. PubMed ID: 15606514
[TBL] [Abstract][Full Text] [Related]
8. Temporal expression of urokinase type plasminogen activator, tissue type plasminogen activator, plasminogen activator inhibitor type 1 in rhesus monkey corpus luteum during the luteal maintenance and regression.
Liu K; Liu YX; Hu ZY; Zou RY; Chen YJ; Mu XM; Ny T
Mol Cell Endocrinol; 1997 Oct; 133(2):109-16. PubMed ID: 9406856
[TBL] [Abstract][Full Text] [Related]
9. Expression of urokinase-type plasminogen activator and its receptor during ovarian follicular development.
Li M; Karakji EG; Xing R; Fryer JN; Carnegie JA; Rabbani SA; Tsang BK
Endocrinology; 1997 Jul; 138(7):2790-9. PubMed ID: 9202219
[TBL] [Abstract][Full Text] [Related]
10. Microglia and the urokinase plasminogen activator receptor/uPA system in innate brain inflammation.
Cunningham O; Campion S; Perry VH; Murray C; Sidenius N; Docagne F; Cunningham C
Glia; 2009 Dec; 57(16):1802-14. PubMed ID: 19459212
[TBL] [Abstract][Full Text] [Related]
11. Expressions of urokinase-type plasminogen activator, its receptor and plasminogen activator inhibitor-1 in gastric cancer cells and effects of Helicobacter pylori.
Iwamoto J; Mizokami Y; Takahashi K; Nakajima K; Ohtsubo T; Miura S; Narasaka T; Takeyama H; Omata T; Shimokobe K; Ito M; Takehara H; Matsuoka T
Scand J Gastroenterol; 2005 Jul; 40(7):783-93. PubMed ID: 16109653
[TBL] [Abstract][Full Text] [Related]
12. Induction of the plasminogen activator system by mechanical stimulation of human bronchial epithelial cells.
Chu EK; Cheng J; Foley JS; Mecham BH; Owen CA; Haley KJ; Mariani TJ; Kohane IS; Tschumperlin DJ; Drazen JM
Am J Respir Cell Mol Biol; 2006 Dec; 35(6):628-38. PubMed ID: 16794260
[TBL] [Abstract][Full Text] [Related]
13. Plasminogen Activation System in Rectal Adenocarcinoma.
Razik E; Kobierzycki C; Grzegrzolka J; Podhorska-Okolow M; Drag-Zalesinska M; Zabel M; Dziegiel P
Anticancer Res; 2015 Nov; 35(11):6009-15. PubMed ID: 26504024
[TBL] [Abstract][Full Text] [Related]
14. Differential localization and expression of urokinase plasminogen activator (uPA), its receptor (uPAR), and its inhibitor (PAI-1) mRNA and protein in endometrial tissue during the menstrual cycle.
Nordengren J; Pilka R; Noskova V; Ehinger A; Domanski H; Andersson C; Høyer-Hansen G; Hansson SR; Casslén B
Mol Hum Reprod; 2004 Sep; 10(9):655-63. PubMed ID: 15243126
[TBL] [Abstract][Full Text] [Related]
15. Regulation and interactions in the activation of cell-associated plasminogen.
Myöhänen H; Vaheri A
Cell Mol Life Sci; 2004 Nov; 61(22):2840-58. PubMed ID: 15558213
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of the urokinase plasminogen activator system by Helicobacter pylori in gastric epithelial cells.
Kenny S; Duval C; Sammut SJ; Steele I; Pritchard DM; Atherton JC; Argent RH; Dimaline R; Dockray GJ; Varro A
Am J Physiol Gastrointest Liver Physiol; 2008 Sep; 295(3):G431-41. PubMed ID: 18599586
[TBL] [Abstract][Full Text] [Related]
17. Renal synthesis of urokinase type-plasminogen activator, its receptor, and plasminogen activator inhibitor-1 in diabetic nephropathy in rats: modulation by angiotensin-converting-enzyme inhibitor.
Kenichi M; Masanobu M; Takehiko K; Shoko T; Akira F; Katsushige A; Takashi H; Yoshiyuki O; Shigeru K
J Lab Clin Med; 2004 Aug; 144(2):69-77. PubMed ID: 15322501
[TBL] [Abstract][Full Text] [Related]
18. Tissue-type plasminogen activator is not necessary for platelet-derived growth factor-c activation.
Riehle KJ; Johnson MM; Johansson F; Bauer RL; Hayes BJ; Gilbertson DG; Haran AC; Fausto N; Campbell JS
Biochim Biophys Acta; 2014 Feb; 1842(2):318-25. PubMed ID: 24269585
[TBL] [Abstract][Full Text] [Related]
19. [Effects of acupoint-embedment of medicated-thread and acupoint-injection on expression of cortical urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in rats with cerebral ischemia-reperfusion injury].
Kong LH; Ye YW; Zhou H; Zhou HJ; Du YJ; Cui CX
Zhen Ci Yan Jiu; 2010 Dec; 35(6):409-14. PubMed ID: 21375013
[TBL] [Abstract][Full Text] [Related]
20. Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator.
Bugge TH; Flick MJ; Danton MJ; Daugherty CC; Romer J; Dano K; Carmeliet P; Collen D; Degen JL
Proc Natl Acad Sci U S A; 1996 Jun; 93(12):5899-904. PubMed ID: 8650190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
